(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

FIG. 1. Association network among the genes harboring the DAVs associated with T2DM as obtained using Pathway Assist. Star denotes genes harboring DAVs of T2DM. NEUROD1, neurogenic differentiation-1; TCF4, hepatic nuclear factor 4 ; TCF1, hepatic nuclear factor 1 ; TNF, tumor necrosis factor; HGF, hepatocyte growth factor; EGF, epidermal growth factor; APOC3, apolipoprotein C3; INS, insulin; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; TGFB, transforming growth factor ß; PPARG, PPAR ; LDL, low density lipoprotein; HDL, high density lipoprotein; PKC, protein kinase C; IFNG, interferon ; IL1B, interleukin-1ß; IL4, interleukin-4; FABP2, fatty acid-binding protein 2; GCK, glucokinase; NOS3, nitric-oxide synthase isoform 3; LPL, lipoprotein lipase; SOD2, superoxide dismutase 2; LEP, leptin; LEPR, leptin receptor; NPY, neuropeptide Y; Prot, protein; Func, function; SmallMol, small molecule; MolTransport, molecular transport; PRKCE, protein kinase C epsilon; ADRB3, ß 3 adrenergic receptor; AGT, angiotensin I; WFS1, wolframin; AKT1, RAC-serine/threonine protein kinase; UTS2, urotensin II; PTEN, phosphotidyl inositol-3,4,5-triphosphate 3-phosphatase; LMNA, lamin A/C; AGER, advanced glycosylation end product-specific receptor; NR3C1, glucocorticoid receptor; TFRC, transferrin receptor; HFE, hereditary hemachromatosis protein; SELL, selectin L; ADRB2, ß 2 adrenergic receptor.
|
Advertisement
Advertisement
|